Education
About Us
Working with TipRanks
Follow Us
Sanofi (DE:SNW)
XETRA:SNW
Total Valuation
Sanofi has a market cap or net worth of €117.63B. The enterprise value is €128.59B.
Market Cap€117.63B
Enterprise Value€128.59B
Share Statistics
Sanofi has 1.23B shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1.23B
Owened by Insiders
Owened by Instutions<0.01%
Financial Efficiency
Sanofi’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is 5.50%.
Return on Equity (ROE)7.17%
Return on Assets (ROA)4.19%
Return on Invested Capital (ROIC)5.50%
Return on Capital Employed (ROCE)7.00%
Revenue Per Employee€700,777.046
Profits Per Employee€50,869.953
Employee Count82,878
Asset Turnover0.33
Inventory Turnover1.40
Valuation Ratios
The current PE Ratio of Sanofi is 21.13. Sanofi’s PEG ratio is 7.00.
PE Ratio21.13
PS Ratio2.65
PB Ratio1.52
Price to Fair Value1.52
Price to FCF19.96
Price to Operating Cash Flow12.93
PEG Ratio7.00
Income Statement
In the last 12 months, Sanofi had revenue of €58.08B and earned €4.22B in profits. Earnings per share was €3.37.
Revenue€58.08B
Gross Profit€39.21B
Operating Income€12.51B
Pretax Income€8.68B
Net Income€4.22B
EBITDA10.93B
Earnings Per Share (EPS)3.37
Cash Flow
In the last 12 months, operating cash flow was €8.12B and capital expenditures -€3.99B, giving a free cash flow of €4.08B billion.
Operating Cash Flow€8.12B
Free Cash Flow€4.08B
Free Cash Flow per Share€3.31
Dividends & Yields
Sanofi pays an annual dividend of €3.92, resulting in a dividend yield of 3.91%
Dividend Per Share€3.92
Dividend Yield3.91%
Payout Ratio48.95%
Free Cash Flow Yield5.01%
Earnings Yield4.73%
Stock Price Statistics
Beta0.53
52-Week Price Change9.26%
50-Day Moving Average104.41
200-Day Moving Average98.57
Relative Strength Index (RSI)38.14
Average Volume (3m)9.63K
Important Dates
Sanofi upcoming earnings date is Apr 24, 2025, Before Open.
Last Earnings DateJan 30, 2025
Next Earnings DateApr 24, 2025
Ex-Dividend DateMay 12, 2025
Financial Position
Sanofi as a current ratio of 1.46, with Debt / Equity ratio of 0.23
Current Ratio1.46
Quick Ratio1.14
Debt to Market Cap0.14
Net Debt to EBITDA0.95
Interest Coverage Ratio9.68
Taxes
In the past 12 months, Sanofi has paid €1.90B in taxes.
Income Tax€1.90B
Effective Tax Rate17.98%
Enterprise Valuation
Sanofi EV to EBITDA ratio is 11.59, with an EV/FCF ratio of 21.73.
EV to Sales2.89
EV to EBITDA11.59
EV to Free Cash Flow21.73
EV to Operating Cash Flow14.09
Balance Sheet
Sanofi has €6.79B in cash and marketable securities with €23.75B in debt, giving a net cash position of €16.96B billion.
Cash & Marketable Securities€6.79B
Total Debt€23.75B
Net Cash€16.96B
Net Cash Per Share€13.75
Tangible Book Value Per Share€9.45
Margins
Gross margin is 70.18%, with operating margin of 16.38%, and net profit margin of 12.55%.
Gross Margin70.18%
Operating Margin16.38%
Pretax Margin15.12%
Net Profit Margin12.55%
EBITDA Margin24.91%
EBIT Margin16.82%
Analyst Forecast
The average price target for Sanofi is €115.58, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target€115.58
Price Target Upside20.31%
Analyst ConsensusModerate Buy
Analyst Count13
Revenue Growth Forecast
EPS Growth Forecast